Billström R, Nilsson P G, Mitelman F
Department of Clinical Genetics, University Hospital, Lund, Sweden.
Eur J Haematol. 1988 Mar;40(3):273-8. doi: 10.1111/j.1600-0609.1988.tb00836.x.
We have analysed survival time and complete remission (CR) rate after induction treatment including cytosine arabinoside and an anthracycline antibiotic in 94 patients with acute myeloid leukaemia, comparing the results in four different groups according to the presence or absence of Auer rods and the presence (AN/AA) or absence (NN) of abnormal cytogenetic clones at diagnosis. The finding of Auer rods was a positive prognostic factor with respect to CR rate (p less than 0.02) and survival time (p less than 0.02) irrespective of the cytogenetic pattern. The AN/AA pattern was associated with lower CR rate (p less than 0.05) and 6-months survival (p = 0.05) in the 49 Auer rod-negative patients. In the 45 patients with Auer rods, no significant differences in CR rate or survival were seen between AN/AA and NN patients. We conclude that the negative prognostic impact of chromosome abnormalities in acute myeloid leukaemia might be restricted to Auer rod-negative disease.
我们分析了94例急性髓系白血病患者在接受包含阿糖胞苷和一种蒽环类抗生素的诱导治疗后的生存时间和完全缓解(CR)率,根据诊断时是否存在奥氏小体以及是否存在异常细胞遗传学克隆(AN/AA)或不存在(NN)将结果分为四个不同组进行比较。无论细胞遗传学模式如何,奥氏小体的存在对于CR率(p<0.02)和生存时间(p<0.02)而言都是一个阳性预后因素。在49例无奥氏小体的患者中,AN/AA模式与较低的CR率(p<0.05)和6个月生存率(p=0.05)相关。在45例有奥氏小体的患者中,AN/AA患者和NN患者之间在CR率或生存率方面未观察到显著差异。我们得出结论,急性髓系白血病中染色体异常的负面预后影响可能仅限于无奥氏小体的疾病。